(Q37864531)

24 August 2017

1 reference

title

Corticobasal degeneration: a pathologically distinct 4R tauopathy (English)

1 reference

corticobasal degeneration

24 August 2017

main subject

1 reference

5

1 reference

24 August 2017

4

Rosa Rademakers

1 reference

24 August 2017

2

Jennifer L Whitwell

1 reference

24 August 2017

Naomi Kouri

1

1 reference

24 August 2017

Keith A Josephs

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

12 April 2011

1 reference

24 August 2017

published in

Nature Reviews Neurology

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

263-272

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.43

24 August 2017

exact match

0 references

cites work

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Cortical-basal ganglionic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Corticobasal degeneration: clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Unusual clinical presentations of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Cognitive and motor assessment in autopsy-proven corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Does corticobasal degeneration exist? A clinicopathological re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Corticobasal degeneration: neuropathologic and clinical heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The clinical overlap between the corticobasal degeneration syndrome and other diseases of the frontotemporal spectrum: three case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The evolution and pathology of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Imaging correlates of pathology in corticobasal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

J. Clifford Richardson and 50 years of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Symmetric corticobasal degeneration (S-CBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Apraxia in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Unraveling progressive supranuclear palsy: from the bedside back to the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Voxel-based morphometry in autopsy proven PSP and CBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinicopathological correlates in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Frontotemporal dementia: clinicopathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinical and pathological characterization of progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Primary progressive aphasia: clinicopathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Posterior cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Progressive posterior cortical dysfunction: a clinicopathologic series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Atypical progressive supranuclear palsy with corticospinal tract degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Regulation of tau pathology by the microglial fractalkine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Targeting tau protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Transgenic animal models of tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Increased CSF tau protein in corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Characterization of tau in cerebrospinal fluid using mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Phosphorylation and cleavage of tau in non-AD tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The distribution of tau in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Tubulin requires tau for growth onto microtubule initiating sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Structure and novel exons of the human tau gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Association of an extended haplotype in the tau gene with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

A common inversion under selection in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Genetic evidence for the involvement of tau in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The role of tau (MAPT) in frontotemporal dementia and related tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Practical application of a low-protein diet for Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Parietal Pick's disease mimicking cortical-basal ganglionic degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Eye movements in parkinsonian syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Frontotemporal lobar degeneration and ubiquitin immunohistochemistry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.43

A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies.

31 March 2020

1 reference

12 December 2020

Clinical and pathological features of corticobasal degeneration

1 reference

12 December 2020

Neuropsychiatric aspects of corticobasal degeneration

1 reference

12 December 2020

Primary progressive aphasia

1 reference

12 December 2020

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

1 reference

12 December 2020

Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline

1 reference

12 December 2020

Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration

1 reference

12 December 2020

Widespread cytoskeletal pathology characterizes corticobasal degeneration

1 reference

12 December 2020

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

1 reference

12 December 2020

Epidemiologic aspects

1 reference

12 December 2020

Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2011.43

1 reference

Dimensions Publication ID

24 August 2017

1041084940

0 references

1 reference